Seborrheic dermatitis treatment

Reading File
Reading File
Searching PubMed

"Dermatitis, Seborrheic"[MeSH Terms] AND "therapy"

Finding Sources
Finding Sources
Searching the Web

seborrheic dermatitis treatment guideline roflumilast foam ketoconazole topical

Let me read the key textbook sections.
Reading File
Reading File

Seborrheic dermatitis: treatment

Seborrheic dermatitis (SD) is a chronic, relapsing condition linked to Malassezia and an inflammatory response. Treatment has three parts: clear the flare, then maintain, and avoid irritating the skin. The standard approach is a topical antifungal plus a short course of anti-inflammatory therapy, then maintenance.

Adults: scalp

  • First line: ketoconazole 2% shampoo, used twice weekly for about 4 weeks. Selenium sulfide, zinc pyrithione, ciclopirox or salicylic acid shampoos also work.
  • Inflamed or thick scale: add a topical corticosteroid. Goldman-Cecil suggests fluocinolone acetonide 0.01% solution, gel or ointment twice daily for 3 to 4 weeks, then ketoconazole shampoo daily or every other day. - Goldman-Cecil Medicine, Seborrheic Dermatitis
  • Maintenance: ketoconazole 2% shampoo about once weekly. Relapse is common without maintenance. Because Malassezia regrows slowly, relapses appear after an interval of weeks, so the maintenance schedule should follow that rhythm. - Dermatology 5e, Adult seborrheic dermatitis

Adults: face and body

  • Mainstay: topical azoles, with response rates of 75 to 90% in double-blind trials. Ciclopirox olamine is also effective. - Dermatology 5e
  • Short-term anti-inflammatory: low-potency steroids, such as hydrocortisone 2.5% twice daily for 1 to 2 weeks. A Cochrane analysis found them about as effective as azoles. Use them for short courses only, because of the risk of skin atrophy and telangiectasia on the face.
  • Steroid-sparing options: topical calcineurin inhibitors (pimecrolimus, tacrolimus). These are off-label but useful for the face and for long-term use. - Dermatology 5e
  • Newer option: roflumilast 0.3% foam, a topical PDE4 inhibitor, is FDA-approved for patients aged 9 and older. In a phase III trial, about 80% of patients were clear or almost clear at 8 weeks, versus 58% on vehicle. This comes from a web summary of the trial, not from the textbooks. A narrative review describes it as the first new SD drug in about 20 years and a possible future first-line agent. It is generally positioned as a second-line choice for now, partly because of cost.

Severe or refractory disease

  • Short course of an oral antifungal, such as itraconazole or weekly fluconazole. Dermatology 5e reserves systemic antimycotics for severe findings or frequent recurrences.
  • Low-dose isotretinoin has been used for recalcitrant cases (per the narrative review above).
  • Check for HIV or Parkinson disease if SD is unusually extensive or inflammatory. Goldman-Cecil notes that SD is more common and more inflammatory in HIV infection.

Infants (cradle cap)

  • Bathing, emollients and mild shampoos are usually enough. Ketoconazole 2% cream can be used for extensive or persistent cases. A brief course of low-potency steroid may be used initially. - Dermatology 5e
  • Avoid strong keratolytics and forceful scale removal.

Practical points

  • Combination therapy is common: an antifungal for the Malassezia, a steroid or calcineurin inhibitor for inflammation, and a keratolytic such as salicylic acid, tar or propylene glycol for thick scale.
  • Ketoconazole foam and gel contain ethanol, which can dry hair.
  • Avoid systemic steroids.
  • Avoid harsh, alcohol-based or irritating products.

Recent evidence check

A 2026 consensus and systematic review (PMID 42976843) proposes a practical treatment algorithm for adults and adolescents. I only saw its title and metadata, not the full abstract, so I can't say whether it changes the approach above. A 2024 systematic review (PMID 39102684) looked at nutrition and obesity in SD. I did not read it. I found nothing in the PubMed search that contradicts the textbook approach.
I can pull images of typical presentations, or give a stepwise algorithm by severity and site, if you want either.
This is a shared conversation. Sign in to Orris to start your own chat.